# Parabilis Medicines IPO (PBLS): price, date and first-day trading

> Parabilis Medicines (PBLS) priced its IPO at $20.00 a share and has traded on Nasdaq since Jun 10, 2026.

Canonical: https://massive.com/quote/pbls/ipo
Data as of: 2026-11-19T09:02:15.306Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## PBLS price

| Figure | Value |
| --- | --- |
| Price | $26.77 |
| Change from the IPO price | +33.85% |
| Change today | -5.24% |

## How PBLS did against the market

PBLS against the market, from its first trade at 12:45 ET to the last trade of the session.

| Measure | Value |
| --- | --- |
| PBLS from its first trade | -3.31% |
| Against the market (QQQ) | -2.5 pts |

## The IPO scoreboard

PBLS against other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

| IPO | Raised | First trade | Day 1 close | Day 5 | Day 30 |
| --- | --- | --- | --- | --- | --- |
| Parabilis Medicines | $670M | +66.75% | +61.22% | +32.25% | +64.25% |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |

## The offering

| Term | Value |
| --- | --- |
| Expected price range | $17 to $19 |
| IPO price | $20.00 |
| Shares offered | 33.5M |
| Money raised | $670M |
| Listing date | Jun 10, 2026 |
| Exchange | Nasdaq |
| Security | Ordinary Shares |

## Where PBLS ranks

The company's market cap against the largest US-listed companies.

| Company | Market cap |
| --- | --- |
| AAPL | $5.12T |
| MSFT | $3.77T |
| NVDA | $3.65T |
| GOOGL | $3.47T |
| AMZN | $2.9T |
| TSM | $1.88T |
| AVGO | $1.69T |
| META | $1.58T |
| TSLA | $1.52T |
| BRK.B | $1.22T |
| PBLS | $3.57B |

## Insider buying and selling after the IPO

From Jun 10, 2026 to Nov 19, 2026, 3 PBLS insiders reported open-market purchases of $7.4M across 3 filings; no open-market sales were filed.

- Peter Kolchinsky, Director: bought $4.7M, filed Jul 22, 2026
- Rajeev M. Shah, Director: bought $2.2M, filed Jul 22, 2026
- Alan Sebulsky, Director: bought $473.5K, filed Jun 16, 2026

Sales made in the offering itself are left out.

[Who traded and when](https://massive.com/quote/pbls/insider-trading.md)

## PBLS news

- [Does Parabilis Medicines (PBLS) Have the Potential to Rally 44.11% as Wall Street Analysts Expect?](https://www.zacks.com/stock/news/3031137/does-parabilis-medicines-pbls-have-the-potential-to-rally-44-11-as-wall-street-analysts-expect?cid=CS-ZC-FT-fundamental_analysis|consensus_price_target-3031137) · Zacks Investment Research · Nov 17, 2026
- [Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors](https://www.globenewswire.com/news-release/2026/10/24/3387680/0/en/parabilis-medicines-presents-updated-phase-1-2-data-for-zolucatetide-demonstrating-compelling-efficacy-and-favorable-safety-and-tolerability-profile-in-patients-with-desmoid-tumors.html) · GlobeNewswire Inc. · Oct 24, 2026
- [Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors](https://www.globenewswire.com/news-release/2026/08/25/3350317/0/en/parabilis-medicines-appoints-accomplished-drug-development-leader-craig-l-tendler-m-d-to-board-of-directors.html) · GlobeNewswire Inc. · Aug 25, 2026
- [Parabilis Soared 58% in the Biggest Biotech IPO on Record. Is It Too Late to Buy the Stock?](https://www.fool.com/investing/2026/06/12/parabilis-soared-58-in-the-biggest-biotech-ipo-on/?source=iedfolrf0000001) · The Motley Fool · Jun 12, 2026
- [Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares](https://www.benzinga.com/pressreleases/26/06/g53155429/parabilis-medicines-announces-closing-of-upsized-initial-public-offering-including-full-exercise-o?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel) · Benzinga · Jun 11, 2026

## Filings and the company

Material events that Parabilis Medicines has disclosed to the SEC on Form 8-K.

- Nov 12, 2026 · Quarterly earnings ([filing](https://www.sec.gov/Archives/edgar/data/1657677/0001193125-26-456892.txt))
- Nov 5, 2026 · Lease agreement ([filing](https://www.sec.gov/Archives/edgar/data/1657677/0001193125-26-449869.txt))
- Sep 2, 2026 · Executive compensation change ([filing](https://www.sec.gov/Archives/edgar/data/1657677/0001193125-26-380171.txt))
- Aug 25, 2026 · Executive compensation change ([filing](https://www.sec.gov/Archives/edgar/data/1657677/0001193125-26-365132.txt))
- Aug 13, 2026 · Investor presentation ([filing](https://www.sec.gov/Archives/edgar/data/1657677/0001193125-26-347869.txt))

## FAQ

### What was the Parabilis Medicines IPO price?

$20.00 a share.

### When did Parabilis Medicines go public?

Parabilis Medicines listed on Nasdaq on Jun 10, 2026 under the ticker PBLS.

### How much did the Parabilis Medicines IPO raise?

$670M, before any underwriters' option.

### How did Parabilis Medicines open on its first day?

PBLS first traded at $33.35, +66.75% from the IPO price of $20.00.

### How did PBLS close on its first day?

Its last regular-session trade was $32.25, +61.22% from the IPO price of $20.00.

### What was the PBLS first-day trading range?

$26.61 to $34.02 in the regular session.

### How many PBLS shares traded on the first day?

5.32M shares in the regular session.

### How many shares did Parabilis Medicines sell in its IPO?

33.5M shares.

### How did PBLS do against the market on its first day?

PBLS fell 3.3% from its first trade to the last trade of the session. That is 2.5 points worse than the market (QQQ, the Nasdaq-100 ETF).

### What exchange is PBLS listed on?

Parabilis Medicines lists on Nasdaq under the ticker PBLS.

## Live data

The IPO record and the price come from the Massive API.

- `GET https://api.massive.com/vX/reference/ipos?ticker=PBLS`
- `GET https://api.massive.com/v3/snapshot?ticker.any_of=PBLS`
- `GET https://api.massive.com/v2/aggs/ticker/PBLS/range/5/minute/{date}/{date}`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Markets overview](https://massive.com/quote/index.md)
- [Insider trading](https://massive.com/quote/insider-trading.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
